CRAD-B C-Rad AB (publ)

2.323USD23.60 SEK · STO-1.26%Mkt Cap: 75.60M USDP/E: 16.74

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company off…

Key Statistics

Company
Market Cap75.60M USD
Enterprise Value-11.41M USD
Revenue (TTM)41.10M USD
Gross Profit31.11M USD
Net Income (TTM)1.03M USD
Revenue/Share1.22 USD
Last Price2.323 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees98
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0002016352
Valuation
P/E (Trailing)16.74
P/E (Forward)10.44
PEG—
EV/EBITDA-1.54
EV/Revenue-0.28
P/S1.84
P/B0.05
EPS (TTM)0.14 USD
EPS (Forward)0.22 USD
52W Range
1.85523% of range3.878
52W High3.878 USD
52W Low1.855 USD
Profitability
Gross Margin71.52%
Oper. Margin16.94%
EBITDA Margin17.99%
Profit Margin2.37%
ROE3.01%
ROA2.09%
ROIC21.57%
ROCE16.89%
Growth
Revenue Growth-23.90%
Earnings Growth-18.40%
Cash Flow & Leverage
Operating CF7.00M USD
CapEx (TTM)2.05M USD
FCF Margin0.54%
FCF Yield0.29%
Net Debt-13.42M USD
Net Debt/EBITDA-1.81
Net Debt/FCF-60.23
Balance Sheet
Debt/Equity0.03
Current Ratio3.46
Quick Ratio2.59
Book Value/Sh42.70 USD
Cash/Share16.45 USD
Dividends
Fwd Div Rate0.0098 USD
Trail. Div Rate0.0098 USD
Div. Yield0.42%
5Y Avg Yield—
Payout Ratio7.09%
Ex-Div DateMay 8, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.445 USD
Upside (mean)+48.3%
Target Range3.445 USD – 3.445 USD
# Analysts1
Ownership
Shares Out.31.68M
Float560.87K
Insiders46.23%
Institutions28.32%
Technical
SMA 502.817 (-17.5%)
SMA 2003.073 (-24.4%)
Beta0.71
S&P 52W Chg12.00%
Avg Vol (30d)89.17K
Avg Vol (10d)61.82K
Technical Indicators
RSI (14)40.7
MACD-1.0121
MACD Signal-1.4253
MACD Hist.+0.4132
BB Upper2.550 USD
BB Middle2.299 USD
BB Lower2.048 USD
BB Width21.82%
ATR (14)0.1583 USD
Vol Ratio (20d)0.25x

About C-Rad (STO: CRAD-B)

›

C-Rad (STO: CRAD-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 98 employees.

The shares were at 23.60 SEK on 19 November 2026, down 26.0% over 52 weeks. Its 52-week range is 18.85 SEK to 39.40 SEK: the price is 40.1% below the high and 25.2% above the low.

At a market capitalisation of 768.10M SEK, it trades at 16.7 times trailing earnings and 10.4 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 35% for CRAD-B. It pays a dividend yielding 0.42% (it pays out 7% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

C-Rad reports return on equity of 3.0%, an operating margin of 16.9% and revenue down 23.9% year over year.

It holds more cash than debt, a net cash position of 136.30M SEK. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 35.00 SEK is 48.3% above the current price.